Estrogens enhance the function of regulatory T cells (Tregs), suppress pro-inflammatory macrophage phenotypes (M1), and reduce the expression of cytokines such as IL-1β, IL-6, and TNF-α—all of which are implicated in the pathogenesis of FS [43,44]. Here, IL6 is linked to Feingold syndrome.